Ozempic Goes Generic in Canada, Prices to Drop
Semaglutide, sold as Ozempic, is now off-patent in Canada. This move could slash costs by up to 75%, dramatically increasing access to the popular diabetes and weight-loss drug for Canadians.
Category : Search result: obesity medication
Novo CEO: Obesity Pill Opens Doors to New Markets
Novo Nordisk's CEO says its new obesity pill will tap into millions not using GLP-1s due to needle fears. The drugmaker battles Eli Lilly and compounders in a massive market.
Massive $8 Pill Organizer Solves Clutter for Canadians
This high-capacity, 7-compartment pill organizer from Amazon declutters counters and simplifies daily routines. At just $7.99, it's a portable, BPA-free solution praised by reviewers.
Fake Erectile Dysfunction Drugs Found in Mississauga
Health Canada issues a public warning about counterfeit Viagra and Cialis tablets found at a Mississauga distributor. Learn how to identify fake medications and protect your health.
Kilos Return Fast After Stopping Weight-Loss Drugs: Study
New research shows patients quickly regain weight after ending GLP-1 medications like Wegovy. Experts stress the need for long-term lifestyle strategies. Learn the findings.
Novo Nordisk Plans Lower-Price Ozempic to Fight Generics
Pharmaceutical giant Novo Nordisk is considering a strategic rebrand of a lower-price version of Ozempic to compete directly with upcoming generic alternatives. Learn about the potential market shift.
Wegovy weight-loss pill launches in U.S. as oral alternative
Novo Nordisk launches Wegovy pill in the U.S., providing a flexible, needle-free option for weight management. Learn about this new alternative to injectable medications.
Doctor on Generic Ozempic: 'Exciting Time for Canada'
Dr. Sue Pedersen advises patients to consult their doctors individually about using generic or brand-name Ozempic. A pivotal moment for diabetes and weight-loss treatment access in Canada.
Trump takes higher aspirin dose than doctors advise
In a lengthy Wall Street Journal interview, former U.S. President Donald Trump disclosed he takes a daily aspirin dose exceeding medical advice. Read the health details.
U.S. Approves Pill Version of Popular Weight-Loss Drug
U.S. regulators have greenlit a pill version of a leading weight-loss medication, potentially broadening treatment options. Learn about the approval and its implications.
Lilly pill keeps weight off after injectable drugs in trial
New data shows Eli Lilly's oral weight-loss drug successfully maintains weight reduction after patients switch from injectable medications. A breakthrough for chronic obesity management.
Chronic pain patients face medication shortages in Canada
Canadians with chronic pain describe the daily struggle of navigating nationwide shortages of essential pain control medications. Learn about the personal impact and ongoing supply issues.
Fake Viagra, Cialis pills seized in Toronto store
Health Canada has seized counterfeit erectile dysfunction medications from a Toronto convenience store. Learn the risks and how to protect yourself from dangerous fake drugs.
Hims & Hers Acquires Livewell for Canadian Expansion
U.S. telehealth giant Hims & Hers acquires Canadian platform Livewell, positioning itself to launch generic semaglutide (Ozempic) in Canada as Novo Nordisk's patent lapses. The move targets a market where two-thirds of adults face weight-related health ch
Novo Nordisk to test obesity drug CagriSema in children
Novo Nordisk, maker of Wegovy, plans clinical trials for its experimental obesity medication CagriSema in overweight children and adolescents. Get the latest details on this significant development in pediatric health.
New HIV prevention guidelines aim to remove barriers to meds
New Canadian guidelines urge doctors to prescribe HIV prevention drugs without gatekeeping. New data shows a slight decline in diagnoses, but rates remain high in the Prairies.
Belly Fat Linked to Dangerous Heart Changes in Men
New research reveals abdominal fat, particularly in men, is strongly linked to dangerous heart remodelling. Learn the risks and what the data means for Canadians.
New HIV guidelines urge doctors to stop gatekeeping PrEP
New Canadian HIV prevention guidelines call for an end to 'gatekeeping' PrEP, urging doctors to offer the preventive medication more readily. Learn about the shift in public health strategy.
WHO Backs GLP-1 Treatments for Obesity Epidemic
The World Health Organization has officially endorsed GLP-1 receptor agonist treatments, including drugs like Ozempic, as a key tool to tackle the global obesity epidemic. Learn what this means for public health.
Eli Lilly cuts price of obesity drug Zepbound
Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.
GLP-1 Drugs Like Ozempic Threaten Fast-Food Business
Experts warn injectable weight-loss drugs such as Ozempic are reducing consumer appetites, posing a significant challenge to the fast-food sector's traditional business model in Canada.
Grey Bruce drug disposal nets meds for hockey tickets
Grey Bruce residents exchanged unused pharmaceuticals for Barrie Colts hockey tickets in a successful medication safety initiative. Learn how this program helps combat opioid misuse and environmental contamination.
Quebec hospital pharmacists plead for help as vacancies hit 20%
Quebec hospital pharmacists demand ministerial action as 1 in 5 positions sit empty, creating medication safety risks. Read about the growing healthcare crisis.
Vets urge changes as animal medicine shortages mount
Canadian veterinarians are pushing for regulatory reforms to address growing medication shortages affecting animal care. Learn about the impacts and proposed solutions.
London collects 230 medications to prevent misuse
London's GBPH initiative successfully collected 230 medications to combat prescription drug misuse. Learn how this community effort protects public health and safety.
Novo's obesity drug shows 14.5% weight loss in trial
Novo Nordisk's experimental obesity drug amycretin demonstrates significant weight loss results in mid-stage study, advancing to late-phase testing for diabetes patients.
Manitoba family seeks coverage for rare disease medication
A Winnipeg family battles for provincial coverage of expensive medication risdiplam to treat a rare genetic disease. Learn how you can support their cause.
India probes cough syrup deaths amid safety concerns
Indian officials are investigating whether safety failures led to children dying from contaminated cough syrup. Get the latest details on this developing health crisis.
GLP-1 Drugs Changing Canadian Food Habits: Study
New research reveals how diabetes medications Ozempic and Wegovy are transforming Canadian shopping patterns and food consumption. Discover the surprising impacts.
Fake Viagra Sold at Toronto Store: Health Canada
Health Canada warns about counterfeit Viagra discovered at a Toronto convenience store. Learn how to identify fake medications and protect your health.
Page 1 of 2